BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9150722)

  • 1. Exclusion of ZFM1 as a candidate gene for multiple endocrine neoplasia type 1 (MEN1).
    Lloyd SE; Pang JT; Pearce SH; Leigh SE; Thakker RV
    Hum Genet; 1997 May; 99(5):585-9. PubMed ID: 9150722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterization of a novel gene encoding nuclear protein at a locus (D11S636) tightly linked to multiple endocrine neoplasia type 1 (MEN1).
    Toda T; Iida A; Miwa T; Nakamura Y; Imai T
    Hum Mol Genet; 1994 Mar; 3(3):465-70. PubMed ID: 7912130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The germinal center kinase gene and a novel CDC25-like gene are located in the vicinity of the PYGM gene on 11q13.
    Kedra D; Seroussi E; Fransson I; Trifunovic J; Clark M; Lagercrantz J; Blennow E; Mehlin H; Dumanski J
    Hum Genet; 1997 Oct; 100(5-6):611-9. PubMed ID: 9341881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic mapping studies of 40 loci and 23 cosmids in chromosome 11p13-11q13, and exclusion of mu-calpain as the multiple endocrine neoplasia type 1 gene.
    Pang JT; Lloyd SE; Wooding C; Farren B; Pottinger B; Harding B; Leigh SE; Pook MA; Benham FJ; Gillett GT; Taggart RT; Thakker RV
    Hum Genet; 1996 Jun; 97(6):732-41. PubMed ID: 8641689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eighteen new polymorphic markers in the multiple endocrine neoplasia type 1 (MEN1) region.
    Manickam P; Guru SC; Debelenko LV; Agarwal SK; Olufemi SE; Weisemann JM; Boguski MS; Crabtree JS; Wang Y; Roe BA; Lubensky IA; Zhuang Z; Kester MB; Burns AL; Spiegel AM; Marx SJ; Liotta LA; Emmert-Buck MR; Collins FS; Chandrasekharappa SC
    Hum Genet; 1997 Nov; 101(1):102-8. PubMed ID: 9385379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping of the gene encoding the B56 beta subunit of protein phosphatase 2A (PPP2R5B) to a 0.5-Mb region of chromosome 11q13 and its exclusion as a candidate gene for multiple endocrine neoplasia type 1 (MEN1).
    Forbes SA; Pannett AA; Bassett JH; Harding B; Wooding C; Thakker RV; Butler R; Ogilvie D; Anand R; Gaudray P; Weber G; Larsson C; Zhang CX; Calender A; Höppener JW; Lips CJ; Kas K
    Hum Genet; 1997 Sep; 100(3-4):481-5. PubMed ID: 9272177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A transcript map encompassing the multiple endocrine neoplasia type-1 (MEN1) locus on chromosome 11q13.
    Sawicki M; Arnold E; Ebrahimi S; Duell T; Jin S; Wood T; Chakrabarti R; Peters J; Wan Y; Samara G; Weier HU; Udar N; Passaro E; Srivatsan ES
    Genomics; 1997 Jun; 42(3):405-12. PubMed ID: 9205112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelic loss of 11q13 as detected by MEN1-FISH is not associated with mutation of the MEN1 gene in lymphoid neoplasms.
    Thieblemont C; Pack S; Sakai A; Beaty M; Pak E; Vortmeyer AO; Wellmann A; Zhuang Z; Jaffe ES; Raffeld M
    Leukemia; 1999 Jan; 13(1):85-91. PubMed ID: 10049065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exclusion of the 13-kDa rapamycin binding protein gene (FKBP2) as a candidate gene for multiple endocrine neoplasia type 1.
    Grimmond S; Weber G; Larsson C; Walters M; Teh B; Shepherd J; Nordenskjold M; Hayward N
    Hum Genet; 1995 Apr; 95(4):455-8. PubMed ID: 7535744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple endocrine neoplasia type 1 (MEN1): LOH studies in a affected family and in sporadic cases.
    Valdes N; Alvarez V; Diaz-Cadorniga F; Aller J; Villazon F; Garcia I; Herrero A; Coto E
    Anticancer Res; 1998; 18(4A):2685-9. PubMed ID: 9703929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of mutations in patients with multiple endocrine neoplasia type 1.
    Bassett JH; Forbes SA; Pannett AA; Lloyd SE; Christie PT; Wooding C; Harding B; Besser GM; Edwards CR; Monson JP; Sampson J; Wass JA; Wheeler MH; Thakker RV
    Am J Hum Genet; 1998 Feb; 62(2):232-44. PubMed ID: 9463336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1.
    Lemmens I; Van de Ven WJ; Kas K; Zhang CX; Giraud S; Wautot V; Buisson N; De Witte K; Salandre J; Lenoir G; Pugeat M; Calender A; Parente F; Quincey D; Gaudray P; De Wit MJ; Lips CJ; Höppener JW; Khodaei S; Grant AL; Weber G; Kytölä S; Teh BT; Farnebo F; Thakker RV
    Hum Mol Genet; 1997 Jul; 6(7):1177-83. PubMed ID: 9215690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linkage analysis of 7 polymorphic markers at chromosome 11p11.2-11q13 in 27 multiple endocrine neoplasia type 1 families.
    Thakker RV; Wooding C; Pang JT; Farren B; Harding B; Anderson DC; Besser GM; Bouloux P; Brenton DP; Buchanan KD
    Ann Hum Genet; 1993 Jan; 57(1):17-25. PubMed ID: 8101435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a 1.2-Mb sequence-ready contig of chromosome 11q13 encompassing the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1.
    Lemmens I; Merregaert J; Van de Ven WJ; Kas K; Zhang CX; Giraud S; Wautot V; Buisson N; De Witte K; Salandre J; Lenoir G; Calender A; Parente F; Quincey D; Courseaux A; Carle GF; Gaudray P; De Wit MJ; Lips CJ; Höppener JW; Khodaei S; Grant AL; Weber G; Kytölä S; Thakker RV
    Genomics; 1997 Aug; 44(1):94-100. PubMed ID: 9286704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human HNP36 gene is localized to chromosome 11q13 and produces alternative transcripts that are not mutated in multiple endocrine neoplasia, type 1 (MEN I) syndrome.
    Williams JB; Rexer B; Sirripurapu S; John S; Goldstein R; Phillips JA; Haley LL; Sait SN; Shows TB; Smith CM; Gerhard DS
    Genomics; 1997 Jun; 42(2):325-30. PubMed ID: 9192854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus.
    Guru SC; Agarwal SK; Manickam P; Olufemi SE; Crabtree JS; Weisemann JM; Kester MB; Kim YS; Wang Y; Emmert-Buck MR; Liotta LA; Spiegel AM; Boguski MS; Roe BA; Collins FS; Marx SJ; Burns L; Chandrasekharappa SC
    Genome Res; 1997 Jul; 7(7):725-35. PubMed ID: 9253601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exclusion of the phosphoinositide-specific phospholipase C beta 3 (PLCB3) gene as a candidate for multiple endocrine neoplasia type 1.
    Weber G; Grimmond S; Lagercrantz J; Friedman E; Phelan C; Carson E; Hayward N; Jacobovitz O; Nordenskjöld M; Larsson C
    Hum Genet; 1997 Jan; 99(1):130-2. PubMed ID: 9003510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exclusion of FAU as the multiple endocrine neoplasia type 1 (MEN1) gene.
    Kas K; Weber G; Merregaert J; Michiels L; Sandelin K; Skogseid B; Thompson N; Nordenskjöld M; Larsson C; Friedman E
    Hum Mol Genet; 1993 Apr; 2(4):349-53. PubMed ID: 8099302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of the MENIN gene in sporadic pancreatic endocrine tumors.
    Wang EH; Ebrahimi SA; Wu AY; Kashefi C; Passaro E; Sawicki MP
    Cancer Res; 1998 Oct; 58(19):4417-20. PubMed ID: 9766672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definition of the minimal MEN1 candidate area based on a 5-Mb integrated map of proximal 11q13. The European Consortium on Men1, (GENEM 1; Groupe d'Etude des Néoplasies Endocriniennes Multiples de type 1).
    Courseaux A; Grosgeorge J; Gaudray P; Pannett AA; Forbes SA; Williamson C; Bassett D; Thakker RV; Teh BT; Farnebo F; Shepherd J; Skogseid B; Larsson C; Giraud S; Zhang CX; Salandre J; Calender A
    Genomics; 1996 Nov; 37(3):354-65. PubMed ID: 8938448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.